Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-09-20

FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for oxybutynin chloride from Lannett Company, granting approval of a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

SUPPL AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)